# Residue-Specific Modulation of Aggregation-Associated Interactions by Spermine in Tau, α‑Synuclein, and Aβ40

**Authors:** Debasis Saha, Xun Sun, Wangfei Yang, Jinghui Luo, Wenwei Zheng

PMC · DOI: 10.1021/jacsau.6c00126 · 2026-03-12

## TL;DR

This study shows how spermine affects the structure of three disease-related proteins, either promoting or preventing harmful clumping depending on specific protein regions.

## Contribution

The paper reveals residue-specific effects of spermine on IDP aggregation, challenging the assumption that net charge alone determines its influence.

## Key findings

- Spermine disrupts aggregation in Tau by binding near the fourth microtubule-binding repeat.
- Spermine enhances α-synuclein aggregation by redistributing contacts in the C-terminal region.
- Spermine promotes Aβ40 fibril formation by neutralizing acidic residues near position 22–24.

## Abstract

Preventing neurodegenerative diseases associated with
intrinsically
disordered proteins (IDPs) remains a major challenge due to the lack
of a detailed, sequence-level picture of disease-relevant structure
formation and the influence of cellular factors that modulate these
transitions. Here, we probe spermine (Spm), a +4 charged polyamine
abundant in cells, to determine how it reshapes the conformational
ensembles and fibril-associated contact propensities of three disease-linked
IDPs: the K18 domain of Tau, α-synuclein (αS), and amyloid-β40
(Aβ40). Using long all-atom molecular dynamics simulations across
a range of Spm concentrations, we quantify residue-level changes in
intrachain contacts relative to native contacts observed in fibrils
and corroborate computational predictions with ThT fluorescence assays
for Tau constructs. Spm acts in a sequence- and region-specific manner,
not simply through the overall net charge. In K18, Spm binds near
the fourth microtubule-binding repeat, disrupting intrachain contacts
associated with Alzheimer’s fibril structures and thereby inhibiting
aggregation. In αS, Spm binds mainly to acidic residues in the
C-terminal half of the sequence and redistributes intramolecular contacts
to enhance aggregation-prone interactions in the central region, providing
a residue-level mechanistic basis for previously reported Spm-enhanced
αS aggregation. For Aβ40, Spm neutralizes acidic residues
near positions 22–24 and shifts intrachain interactions toward
its aggregation-prone core, resulting in a net promotion of fibril-like
conformations. These divergent effects show that net charge alone
cannot predict the polyamine influence on IDPs. Instead, residue-specific
binding hotspots and local reweighting of aggregation-linked contacts
determine whether Spm promotes or suppresses fibril-like conformations.
This combined simulation–experimental framework provides a
mechanistic basis for how small molecules reprogram IDP conformational
ensembles and suggests principles for designing ligands that exploit
similar residue-level modulation.

## Linked entities

- **Proteins:** MAPT (microtubule associated protein tau), HLA-B (major histocompatibility complex, class I, B)
- **Chemicals:** spermine (PubChem CID 1103), ThT (PubChem CID 1127)

## Full-text entities

- **Genes:** LINC02605 (long intergenic non-protein coding RNA 2605) [NCBI Gene 112935892] {aka AS, IL-7, IL-7-AS}, KRT18 (keratin 18) [NCBI Gene 3875] {aka CK-18, CYK18, K18}, MAPT (microtubule associated protein tau) [NCBI Gene 4137] {aka DDPAC, FTD1, FTDP-17, MAPTL, MSTD, MTBT1}, IDH1 (isocitrate dehydrogenase (NADP(+)) 1) [NCBI Gene 3417] {aka HEL-216, HEL-S-26, IDCD, IDH, IDP, IDPC}, SNCA (synuclein alpha) [NCBI Gene 6622] {aka NACP, PARK1, PARK4, PD1}
- **Diseases:** Alzheimer's (MESH:D000544), neurodegenerative diseases (MESH:D019636)
- **Chemicals:** Spermine (MESH:D013096), ThT (MESH:C121030), polyamine (MESH:D011073)

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13014203/full.md

---
Source: https://tomesphere.com/paper/PMC13014203